Literature DB >> 19651580

Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.

William B Brinkman1, Susan N Sherman, April R Zmitrovich, Marty O Visscher, Lori E Crosby, Kieran J Phelan, Edward F Donovan.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral conditions of childhood and adolescence. Despite availability of effective treatment options, initiation of treatment is variable and persistence with therapeutic regimens is poor.
OBJECTIVE: We sought to better understand how parents make decisions about treatment for their child or adolescent with ADHD.
METHODS: We conducted a qualitative study among parents of children and adolescents; 52 parents participated in 1 of 12 focus groups. Parents answered questions about decision-making, information sharing, and sources of conflict and uncertainty. Sessions were audiotaped and transcribed verbatim. Themes were coded independently by 4 of the investigators, who then agreed on common themes.
RESULTS: Parents in our study made decisions about treatment for their child with ADHD in the midst of experiencing a variety of emotions as they witnessed child functional impairments at home and at school. In addition, parents felt stress as a result of their daily efforts to manage their child's struggles. Multiple factors influenced the decision to initiate medication. Subsequently, revisiting the decision to give their child medicine for ADHD was common. Many parents contrasted time on and off medicine to help inform management decisions. Trials stopping medication were almost always parent- or child-initiated.
CONCLUSIONS: Decisions about medication use for children and adolescents with ADHD are made and frequently revisited by their parents. Choices are often made under stressful conditions and influenced by a variety of factors. Striking a balance between benefits and concerns is an ongoing process that is often informed by contrasting time on and off medication. Development of strategies to support families across the continuum of decisions faced while managing ADHD is warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651580     DOI: 10.1542/peds.2008-2569

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  45 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  Physicians' shared decision-making behaviors in attention-deficit/hyperactivity disorder care.

Authors:  William B Brinkman; Jessica Hartl; Lauren M Rawe; Heidi Sucharew; Maria T Britto; Jeffery N Epstein
Journal:  Arch Pediatr Adolesc Med       Date:  2011-11

3.  Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder.

Authors:  Daniel J Coletti; Elizabeth Pappadopulos; Nikki J Katsiotas; Alison Berest; Peter S Jensen; Vivian Kafantaris
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

4.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

5.  The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

Authors:  Anton Pottegård; Bine Kjøller Bjerregaard; Dorte Glintborg; Lisbeth Sandal Kortegaard; Jesper Hallas; Søren Ilsøe Moreno
Journal:  Eur J Clin Pharmacol       Date:  2012-07-19       Impact factor: 2.953

6.  Shared Decision Making in the Care of Children with Developmental and Behavioral Disorders.

Authors:  Ellen A Lipstein; Olivia J Lindly; Julia S Anixt; Maria T Britto; Katharine E Zuckerman
Journal:  Matern Child Health J       Date:  2016-03

Review 7.  An emerging field of research: challenges in pediatric decision making.

Authors:  Ellen A Lipstein; William B Brinkman; Alexander G Fiks; Kristin S Hendrix; Jennifer Kryworuchko; Victoria A Miller; Lisa A Prosser; Wendy J Ungar; David Fox
Journal:  Med Decis Making       Date:  2014-08-21       Impact factor: 2.583

8.  Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.

Authors:  William B Brinkman; John O Simon; Jeffery N Epstein
Journal:  Acad Pediatr       Date:  2017-09-12       Impact factor: 3.107

9.  High Levels of Decisional Conflict and Decision Regret When Making Decisions About Biologics.

Authors:  Ellen A Lipstein; Daniel J Lovell; Lee A Denson; Sandra C Kim; Charles Spencer; Richard F Ittenbach; Maria T Britto
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

10.  Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV.

Authors:  Patricia A Sirois; Lisa Aaron; Grace Montepiedra; Deborah A Pearson; Suad Kapetanovic; Paige L Williams; Patricia A Garvie; Molly L Nozyce; Kathleen Malee; Sharon L Nichols; Betsy L Kammerer; Wendy G Mitchell; Mark Mintz; James M Oleske
Journal:  Pediatr Infect Dis J       Date:  2016-01       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.